000 01304 a2200397 4500
005 20250512015346.0
264 0 _c19890906
008 198909s 0 0 eng d
022 _a0007-0912
024 7 _a10.1093/bja/62.6.596
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLawson, D H
245 0 0 _aAtracurium--a post-marketing surveillance study: U.K. study and discussion.
_h[electronic resource]
260 _bBritish journal of anaesthesia
_cJun 1989
300 _a596-600 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnesthesia Recovery Period
650 0 4 _aAtracurium
_xadverse effects
650 0 4 _aCardiovascular Diseases
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIntraoperative Complications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aScotland
650 0 4 _aUnited Kingdom
700 1 _aPaice, G M
700 1 _aGlavin, R J
700 1 _aAndrews, E B
700 1 _aBranche, C
700 1 _aTilson, H
700 1 _aJick, H
773 0 _tBritish journal of anaesthesia
_gvol. 62
_gno. 6
_gp. 596-600
856 4 0 _uhttps://doi.org/10.1093/bja/62.6.596
_zAvailable from publisher's website
999 _c2757781
_d2757781